Skip to main content
. 2019 Oct 10;9:14503. doi: 10.1038/s41598-019-51021-2

Figure 2.

Figure 2

A comparison of the fucosylated AGP level between before and after administration of nivolumab. The fAGP level in each patient (n = 39) was measured before and after starting the administration of nivolumab. Accordingly, the fAGP level was measured at baseline and at 1 month in most of the patients and at 3 (No. 36) and 6 month (Nos 34, 38 and 39). The former was commonly indicated with a black-colored bar, and the latter was with differently-colored bars grouped according to the classification of the RECIST criteria28 conducted at the moment; PD (red), SD (yellow) and PR (blue), respectively. The solid line at 16.67 U/μg indicates the cut-off value. A gray-colored screen indicates patients who were alive during the observation time (see the details in Text).